Pourquoi 50% des patients abandonnent leur traitement en cours?16/11/2012
ecancer – Conference highlights and events calendar16/11/2012
I was pleased to lead a panel discussion on this topic at the Centric Ultra Orphan Conference in St. Louis in September. We discussed the new model for pharma that puts a greater focus on patient advocacy and identifying patient expectations.
See on sirensong.sireninteractive.com